GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 100 filers reported holding GENERATION BIO CO in Q4 2022. The put-call ratio across all filers is 5.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | -7.3% | 13,430 | +5.8% | 0.00% | 0.0% |
| Q1 2023 | $55 | -17.9% | 12,699 | -25.5% | 0.00% | 0.0% |
| Q4 2022 | $67 | -99.9% | 17,052 | +8.2% | 0.00% | 0.0% |
| Q3 2022 | $84,000 | -28.8% | 15,764 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $118,000 | -78.6% | 18,032 | -18.1% | 0.00% | -66.7% |
| Q3 2021 | $552,000 | +119.9% | 22,014 | +149.2% | 0.00% | +200.0% |
| Q1 2021 | $251,000 | – | 8,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |